Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 3/2021

Open Access 01-06-2021 | Acne | Commentary

A New Era for Truncal Acne: Emerging from a Legacy of Neglect

Authors: Jerry K. L. Tan, Thomas Dirschka

Published in: Dermatology and Therapy | Issue 3/2021

Login to get access

Excerpt

Truncal acne, despite its prevalence, physical and psychological burden, has largely been neglected in prior clinical trials and guidelines.
Recognizing and addressing this shortcoming may reduce the overall burden of acne.
The potential effectiveness of some topical treatments in truncal acne challenge the role of systemic agents.
High-quality studies in truncal and facial acne are needed to expand the evidence base and inform treatment decisions.
In clinical practice, the evaluation and management of both facial and truncal acne, as well as exploring the overall burden, can address the comprehensive needs of our patients.
…
Literature
1.
Del Rosso JQ, et al. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol. 2007;6(6):597–600.PubMed
2.
Hassan J, et al. The individual health burden of acne. J Health Psychol. 2009;14(8):1105–18.CrossRef
3.
Asai Y, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016;188:118–26.CrossRef
4.
Bikowski J. A review of the safety and efficacy of benzoyl peroxide (5.3%) emollient foam in the management of truncal acne vulgaris. J Clin Aesthet Dermatol. 2010;3(11):26–9.PubMedPubMedCentral
5.
Liu C, Tan J. Understanding truncal acne: a practical guide to diagnosis and management. Skin Ther Lett. 2017.
6.
Tan J, et al. Randomized phase 3 evaluation of trifarotene 50 µg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691–9.CrossRef
7.
Blume-Peytavi U, et al. Long-term safety and efficacy of trifarotene 50 µg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2020;34(1):166–73.CrossRef
Metadata
Title
A New Era for Truncal Acne: Emerging from a Legacy of Neglect
Authors
Jerry K. L. Tan
Thomas Dirschka
Publication date
01-06-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 3/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00529-5

Other articles of this Issue 3/2021

Dermatology and Therapy 3/2021 Go to the issue

Original Research

Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case–Control Study

Commentary

Why We Should Consider Evidence-Based Treatment Options for Truncal Acne

Review

Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review

Commentary

Repurposing Belinostat for Alleviation of Atopic Dermatitis

Original Research

Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous Melanoma

Original Research

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits